Fumarylacetoacetate, the metabolite accumulating in hereditary tyrosinemia, activates the ERK pathway and induces mitotic abnormalities and genomic instability.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples